Free Trial

NeuBase Therapeutics (NBSE) SEC Filings & 10K Form

→ Millionaire investor and Republican donor makes surprising election prediction (From InvestorPlace) (Ad)
Free NBSE Stock Alerts
$0.38
-0.01 (-3.20%)
(As of 05/10/2024 03:59 PM ET)
Compare
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability

Recent NeuBase Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
05/06/2024
6:30 AM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form DEFA14A
04/05/2024
3:16 PM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
3:46 PM		GREENLIGHT CAPITAL INC (Filed by)
NeuBase Therapeutics, Inc. (Subject)
NeuBase Therapeutics (Subject)
Form SC 13G/A
01/26/2024
7:00 AM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2024
5:15 AM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
6:00 AM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
5:15 AM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form 424B3
12/22/2023
5:15 AM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2023
6:30 AM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2023
7:00 AM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2023
3:10 PM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2023
7:42 PM		NeuBase Therapeutics, Inc. (Issuer)
NeuBase Therapeutics (Issuer)
Shiff Aleta (Reporting)
Shiff Barry (Reporting)
Symetryx Corp (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
09/20/2023
4:28 PM		NeuBase Therapeutics, Inc. (Subject)
NeuBase Therapeutics (Subject)
Symetryx Corp (Filed by)
Form SC 13D/A
09/18/2023
3:32 PM		NeuBase Therapeutics, Inc. (Issuer)
NeuBase Therapeutics (Issuer)
Symetryx Corp (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2023
3:17 PM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
3:20 PM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form DEFA14A
09/14/2023
5:03 AM		NeuBase Therapeutics, Inc. (Subject)
NeuBase Therapeutics (Subject)
Symetryx Corp (Filed by)
Form SC 13D/A
09/12/2023
4:20 PM		NeuBase Therapeutics, Inc. (Issuer)
NeuBase Therapeutics (Issuer)
Shiff Aleta (Reporting)
Shiff Barry (Reporting)
Symetryx Corp (Reporting)
Form 3/A
09/11/2023
4:08 PM		NeuBase Therapeutics, Inc. (Issuer)
NeuBase Therapeutics (Issuer)
Symetryx Corp (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2023
4:19 PM		NeuBase Therapeutics, Inc. (Issuer)
NeuBase Therapeutics (Issuer)
Symetryx Corp (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
1:51 PM		NeuBase Therapeutics, Inc. (Issuer)
NeuBase Therapeutics (Issuer)
Symetryx Corp (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/11/2023
5:18 AM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form DEFA14A
08/11/2023
5:20 AM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form ARS
08/10/2023
11:15 PM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form EFFECT
08/11/2023
5:15 AM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form DEF 14A
08/04/2023
3:39 PM		NeuBase Therapeutics, Inc. (Issuer)
NeuBase Therapeutics (Issuer)
Stephan Dietrich A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2023
6:05 AM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2023
3:45 PM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form PRE 14A
07/31/2023
3:10 PM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2023
5:03 AM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/07/2023
3:11 PM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
06/30/2023
3:21 PM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2023
7:41 AM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form 424B3
06/30/2023
7:42 AM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form 424B5
05/22/2023
6:00 AM		NeuBase Therapeutics, Inc. (Filer)
NeuBase Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:NBSE) was last updated on 5/13/2024 by MarketBeat.com Staff

From Our Partners
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
Dave Ramsey Shocks Millions With US Dollar Lunacy
American Hartford Gold Group
Does this make you sick?
Allegiance Gold
The Department of Defense Has a New Drone Contractor
The Tomorrow Investor
This 1 Biotech Stock has been shocking the markets
Huge Alerts
Next President (Not Trump. Not Biden.)
The Freeport Society
Have you heard of the $11 AI Coin?
InvestorPlace
The 2024 Gold Rush: Unleashing Market Potential
Priority Gold